Literature DB >> 35862648

Small hairpin inhibitory RNA delivery in the metanephric organ culture identifies long noncoding RNA Pvt1 as a modulator of cyst growth.

Kara Eckberg1, Ivan Weisser1, Daniel Buttram1, Nikunj Somia2, Peter Igarashi1, Karam S Aboudehen1.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a monogenic disorder characterized by the formation of kidney cysts that originate from the epithelial tubules of the nephron and primarily results from mutations in polycystin-1 (PKD1) and polycystin-2 (PKD2). The metanephric organ culture (MOC) is an ex vivo system in which explanted embryonic kidneys undergo tubular differentiation and kidney development. MOC has been previously used to study polycystic kidney disease as treatment with 8-bromo-cAMP induces the formation of kidney cysts. However, the inefficiency of manipulating gene expression in MOC has limited its utility for identifying genes and pathways that are involved in cystogenesis. Here, we used a lentivirus and three serotypes of self-complementary adeno-associated viral (scAAV) plasmids that express green fluorescent protein and found that scAAV serotype D/J transduces the epithelial compartment of MOC at an efficiency of 68%. We used scAAV/DJ to deliver shRNA to knockdown Pvt1, a long noncoding RNA, which was upregulated in kidneys from Pkd1 and Pkd2 mutant mice and humans with ADPKD. shRNA delivery by scAAV/DJ downregulated expression of Pvt1 by 45% and reduced the cyst index by 53% in wild-type MOCs and 32% in Pkd1-null MOCs. Knockdown of Pvt1 decreased the level of c-MYC protein by 60% without affecting Myc mRNA, indicating that Pvt1 regulation of c-MYC was posttranscriptional. These results identify Pvt1 as a long noncoding RNA that modulates cyst progression in MOC.NEW & NOTEWORTHY This study identified scAAV/DJ as effective in transducing epithelial cells of the metanephric organ culture (MOC). We used scAAV/DJ shRNA to knockdown Pvt1 in cystic MOCs derived from Pkd1-null embryos. Downregulation of Pvt1 reduced cyst growth and decreased levels of c-MYC protein. These data suggest that suppression of Pvt1 activity in autosomal dominant polycystic kidney disease might reduce cyst growth.

Entities:  

Keywords:  Pvt1; c-MYC; metanephric organ culture; polycystic kidney disease; self-complementary adeno-associated virus

Mesh:

Substances:

Year:  2022        PMID: 35862648      PMCID: PMC9423782          DOI: 10.1152/ajprenal.00016.2022

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  66 in total

Review 1.  Genetics and pathogenesis of polycystic kidney disease.

Authors:  Peter Igarashi; Stefan Somlo
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

2.  Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element.

Authors:  Seung Woo Cho; Jin Xu; Ruping Sun; Maxwell R Mumbach; Ava C Carter; Y Grace Chen; Kathryn E Yost; Jeewon Kim; Jing He; Stephanie A Nevins; Suet-Feung Chin; Carlos Caldas; S John Liu; Max A Horlbeck; Daniel A Lim; Jonathan S Weissman; Christina Curtis; Howard Y Chang
Journal:  Cell       Date:  2018-05-03       Impact factor: 41.582

3.  PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein.

Authors:  T Mochizuki; G Wu; T Hayashi; S L Xenophontos; B Veldhuisen; J J Saris; D M Reynolds; Y Cai; P A Gabow; A Pierides; W J Kimberling; M H Breuning; C C Deltas; D J Peters; S Somlo
Journal:  Science       Date:  1996-05-31       Impact factor: 47.728

4.  Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b.

Authors:  Shaorong Zhang; Guanli Zhang; Jingying Liu
Journal:  APMIS       Date:  2016-06-08       Impact factor: 3.205

5.  Polycystin-1 distribution is modulated by polycystin-2 expression in mammalian cells.

Authors:  David H Grimm; Yiqiang Cai; Veronique Chauvet; Vanathy Rajendran; Raoul Zeltner; Lin Geng; Ellis D Avner; William Sweeney; Stefan Somlo; Michael J Caplan
Journal:  J Biol Chem       Date:  2003-07-02       Impact factor: 5.157

6.  AAV-Mediated Gene Therapy for Research and Therapeutic Purposes.

Authors:  R Jude Samulski; Nicholas Muzyczka
Journal:  Annu Rev Virol       Date:  2014-11       Impact factor: 10.431

7.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

8.  Microinjection and electroporation of embryonic kidney explants: an improved method.

Authors:  T M Alie; P J Vrljicak; D B Myburgh; I R Gupta
Journal:  Kidney Int       Date:  2007-05-09       Impact factor: 10.612

9.  Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia.

Authors:  Vishal Patel; Ling Li; Patricia Cobo-Stark; Xinli Shao; Stefan Somlo; Fangming Lin; Peter Igarashi
Journal:  Hum Mol Genet       Date:  2008-02-09       Impact factor: 6.150

10.  Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation.

Authors:  Jamie A Davies; Michael Ladomery; Peter Hohenstein; Lydia Michael; Anna Shafe; Lee Spraggon; Nick Hastie
Journal:  Hum Mol Genet       Date:  2003-11-25       Impact factor: 6.150

View more
  1 in total

1.  Expression profile of long non-coding RNA in inner Mongolian cashmere goat with putative roles in hair follicles development.

Authors:  Rong Ma; Fangzheng Shang; Youjun Rong; Jianfeng Pan; Min Wang; Shuran Niu; Yunpeng Qi; Yanbo Li; Qi Lv; Zhiying Wang; Ruijun Wang; Rui Su; Zhihong Liu; Yanhong Zhao; Zhixin Wang; Jinquan Li; Yanjun Zhang
Journal:  Front Vet Sci       Date:  2022-09-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.